title: Regulating the pharmaceutical industry. General public does not support value system inherent in cost effectiveness analyses.
authors.forename: J
authors.initials: J
authors.lastname: Furniss
authors.forename: J
authors.initials: J
authors.lastname: Zammit-Lucia
authors.forename: N
authors.initials: N
authors.lastname: Johnson
mesh_terms: D003362:Cost-Benefit Analysis; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D011639:Public Opinion; D006113:United Kingdom